Literature DB >> 7251567

Refractory depression: prediction of non-response by clinical indicators.

D J Kupfer, D G Spiker.   

Abstract

The prediction of non-response in a well-defined group of 76 inpatients with a major depressive syndrome was made on the basis of clinical data. While agitation, anxiety, presence of delusions and bipolarity were significant factors, previously considered predictors (e.g. endogenous subtype, duration of present episode, number of previous episodes) did not contribute to the successful discrimination of response in this group at three levels: Clear-cut response, partial response and non-response. Since this investigation has carefully controlled for drug withdrawal and washout phases, medical complications and antidepressant drug compliance, the results of earlier studies may need to be reevaluated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251567

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

1.  Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.

Authors:  Maura L Furey; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2006-10

Review 2.  Major depressive disorder with psychotic features may lead to misdiagnosis of dementia: a case report and review of the literature.

Authors:  Gerhardt S Wagner; Shawn M McClintock; Peter B Rosenquist; W Vaughn McCall; David A Kahn
Journal:  J Psychiatr Pract       Date:  2011-11       Impact factor: 1.325

Review 3.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

4.  Prediction of short-term outcome of neurotic-depressive inpatients. Results of an empirical study of 134 inpatients.

Authors:  H J Möller; M Krokenberger; D von Zerssen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 5.  Prevalence and outcome of partial remission in depression.

Authors:  Richard Tranter; Claire O'Donovan; Praful Chandarana; Sidney Kennedy
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

Review 6.  Psychosocial and clinical predictors of response to pharmacotherapy for depression.

Authors:  R Michael Bagby; Andrew G Ryder; Carolina Cristi
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

7.  Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.

Authors:  Wayne C Drevets; Maura L Furey
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382

8.  Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients.

Authors:  H J Möller; G Fischer; D von Zerssen
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

9.  Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale.

Authors:  Sol A Park; Sang Won Jeon; Ho-Kyoung Yoon; Seo Young Yoon; Cheolmin Shin; Young-Hoon Ko
Journal:  Psychiatry Investig       Date:  2017-10-12       Impact factor: 2.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.